Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 16, 2013 02:30 ET | Source: Active Biotech

Annual General Meeting of Active Biotech AB

The Annual General Meeting of Active Biotech was held on May 15, 2013. In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid. In accordance with the...
May 16, 2013 02:30 ET | Source: Active Biotech

New data to be presented at the 2013 ASCO Annual Meeting show Active Biotech's commitment to oncology research

Lund, Sweden, May 16, 2013, Active Biotech (NASDAQ OMX NORDIC: ACTI) will present data from two of its oncology projects, the drug candidates tasquinimod for the treatment of prostate cancer and...
April 25, 2013 02:30 ET | Source: Active Biotech

Active Biotech AB Interim Report January - March 2013

Laquinimod · first patient enrolled in CONCERTO, the third Phase III placebo-controlled study for the treatment of relapsing-remitting multiple sclerosis · data presented at AAN showed reduced...
April 25, 2013 02:30 ET | Source: Active Biotech

Active Biotech AB Delårsrapport januari - mars 2013

Laquinimod · första patienten rekryterad till CONCERTO, den tredje placebokontrollerade fas III-studien för behandling av relapserande remitterade multipel skleros· data presenterade på AAN visar en...
April 25, 2013 01:00 ET | Source: Active Biotech

Active Biotech and Ipsen update the analysis plan for the 10TASQ10 trial evaluating tasquinimod in the treatment of prostate cancer

Primary PFS analysis now expected at the same time as first interim overall survival analysis in 2014 Lund (Sweden) and Paris (France), 25 April, 2013, Active Biotech (NASDAQ OMX NORDIC: ACTI)...
April 25, 2013 01:00 ET | Source: Active Biotech

Active Biotech och Ipsen uppdaterar analysplanen för studien 10TASQ10 vilken utvärderar tasquinimod för behandling av prostatacancer

Primär PFS-analys förväntas nu samtidigt med den första interimsanalysen för överlevnad 2014 Lund, Sverige och Paris, Frankrike den 25 april 2013, Active Biotech (NASDAQ OMX NORDIC: ACTI) och...
April 15, 2013 04:00 ET | Source: Active Biotech

Annual Report 2012 Active Biotech AB (publ)

Active Biotech's Annual Report 2012 (in Swedish) is now available for download at www.activebiotech.com. The English version will be available within short. The Annual Report will only be...
April 15, 2013 04:00 ET | Source: Active Biotech

Årsredovisning 2012 Active Biotech AB (publ)

Active Biotechs årsredovisning för 2012 finns nu tillgänglig på www.activebiotech.com. Årsredovisningen kommer enbart att distribueras digitalt. Lund den 15 april 2013Active Biotech AB (publ)...
April 11, 2013 02:30 ET | Source: Active Biotech

Active Biotech - Notice of Annual General Meeting of Shareholders

The Board of Directors of Active Biotech AB (publ) has issued a notice to the Annual General Meeting, which is to take place at 5 p.m. on Wednesday, May 15, 2013, at Edison Park, Emdalavägen 16 in...
April 11, 2013 02:30 ET | Source: Active Biotech

Active Biotech - Kallelse till årsstämma

Styrelsen för Active Biotech AB (publ) har utfärdat kallelse till årsstämma, vilken kommer äga rum onsdagen den 15 maj 2013 klockan 17.00 på Edison Park, Emdalavägen 16 i Lund. Kallelsen, som inom...